Anthropic also went a step further, saying it would develop drugs of its own. Head of life sciences Eric Kauderer-Abrams said ...

Introducing Claude Science, the AI platform designed to expedite the discovery of promising new therapies. Anthropic will ...

AI-driven drug discovery, using LLMs and diffusion models, has improved drug design and reduced timelines. Although promising ...

AI is transforming medicine development by accelerating drug discovery and clinical trials, reducing costs, and enhancing the efficiency of pharmaceutical processes.

Lonza will add commercial-scale manufacturing for highly complex HPAPIs and ADC payload linkers at Visp, expanding capacity ...

The drug discovery services market is projected to advance from US$ 21.5 billion in 2026 to US$ 67.3 billion by 2035, compounding at a CAGR of 13.5 per cent over the forecast period. The market had ...

Tsingke Biotech recently hosted the Oligonucleotide Drug Salon at the Hilton Shanghai Zhangjiang, bringing together experts from academia, biopharmaceutical companies, investment firms, and industry ...

A new laser technique decodes molecular vibrations to predict whether a drug will be effective, potentially cutting years ...

New collaboration delivers streamlined integration from drug substance to drug product, including sterile fill-finish and device assembly for clinical programs.

ALP Bio is developing an AI-powered platform that helps drug developers identify immune-related risks earlier in the ...

While multinational pharmaceutical companies use India to test out their new medicines, India’s researchers rarely lead the ...

A team of researchers at the University of Warwick and Monash University has solved a puzzle that has stumped drug developers ...